trial
as of 2026-07-01Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness
NCTId NCT02167620
at a glance
Phase 4 · Completed
Enrollment 35 (actual)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2018-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
35 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2014-06
Primary completion
2018-02
Eligibility
ALL · 17 Years · 45 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Investigators
1
Margaret K Hahn, PhD, MDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
35
Phase
PHASE4
Primary Completion Date
2018-02
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator
person